Dopa-Responsive Parkinsonism in a Patient With Homozygous RFC1 Expansions

Mov Disord. 2020 Oct;35(10):1890-1891. doi: 10.1002/mds.28279.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Atrophy
  • Humans
  • Levodopa / therapeutic use
  • Multiple System Atrophy*
  • Parkinsonian Disorders* / drug therapy
  • Parkinsonian Disorders* / genetics

Substances

  • Levodopa